Global Small Molecule Active Pharmaceutical Ingredient (API) Manufacturing Market Report 2021


Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) — “Contractual Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition” report has been added to from offer.

This report characterizes the Small Molecule Active Pharmaceutical Ingredient (API) Contract Manufacturing industry across a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and the financial performance of major contract manufacturing organizations (CMOs).

Contract manufacturing of small molecule APIs is essential to establishing an understanding of the small molecule API CMO industry and the characteristics of some of the largest CMOs participating in the industry.

This report gives important and expert information that you will not find in any other source. 31 tables and figures throughout the report illustrate key points and trends.

This report is required reading for:

  • CMO leaders who must have a deep understanding of the small molecule API market to make strategic planning and investment decisions.
  • Procurement and procurement managers who need to understand the critical elements of the supply base in order to make decisions regarding vendor selection and management.
  • Private equity investors who need a deeper understanding of the market to identify and assess potential investment targets.

Reasons to buy

  • Overview of Small Molecule API Contract Facilities and Proportion of Dedicated Containment and Controlled Substances Capabilities
  • Detailed view of the geographical distribution of small molecule API facilities
  • Establish which CMOs are most involved in the contract small molecule API industry by number of facilities
  • Analysis of M&A activity related to small molecule API facilities

Main topics covered:

1. Summary

2 players

3 Trends

4 Industry Analysis
4.1 Industry Size and Structure
4.2 Industry Demographics
4.3 Top CMOs by Small Molecule API Facilities
4.4 Characteristics of the largest CMOs

5 Merger and Acquisition Activity Involving Small Molecule Contract Manufacturing Facilities

6 API CMO Industry Outlook

7 Value chain

8 Companies

9 Appendix

Companies cited

  • Jetpharma AG
  • Scientia Life Sciences LLC
  • Godavari Medicines Ltd.
  • Chifeng Yingfa Pharmaceutical Co Ltd
  • Jiangxi Xinganjiang Pharmaceutical Co Ltd
  • Midwest Pharmaceuticals NZ Ltd
  • Aragen Life Sciences Pvt Ltd
  • Gufic BioSciences Ltd
  • Microfine Pharma Pvt Ltd
  • Chemistry Laboratories Inc.
  • Hainan Shuangcheng Pharmaceuticals Co Ltd
  • Arene Lifesciences Pvt Ltd
  • FOB Synthesis Inc
  • Jiangxi Aifeimu Technology Co Ltd
  • Fleming Laboratories Ltd.
  • Alkaloid Society
  • Lianyungang Guike Pharmaceutical Co Ltd
  • AR Life Sciences Pvt Ltd
  • Lianyungang Jinkang Pharmaceutical Technology Co Ltd
  • Cangzhou Enke Pharma-tech Co Ltd
  • Hubei Yitai Pharmaceutical Co Ltd
  • Inga Pharmaceuticals
  • Sintez Pharmacy
  • Beximco Pharmaceuticals Ltd
  • Lianyungang Hengfei Pharmaceutical Co Ltd
  • AS antibiotic
  • Accrete Pharmaceuticals Pvt Ltd
  • Micro-Sphere SA
  • Farmak AS
  • Aktinos Pharma Pvt Ltd

For more information on this report, visit

Source: Global Data

         Laura Wood, Senior Press Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

main logo


Comments are closed.